Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan-Mar;21(1):2761.
doi: 10.18549/PharmPract.2023.1.2761. Epub 2022 Dec 21.

The effect of omega-3 supplements on the serum levels of ACE/ACE2 ratio as a potential key in cardiovascular disease: A randomized clinical trial in participants with vitamin D deficiency

Affiliations

The effect of omega-3 supplements on the serum levels of ACE/ACE2 ratio as a potential key in cardiovascular disease: A randomized clinical trial in participants with vitamin D deficiency

Sara M Daboul et al. Pharm Pract (Granada). 2023 Jan-Mar.

Abstract

Objective: The aim of this randomized controlled clinical trial was to determine the effect of the omega-3 fatty acid supplementations 300 mg per day for 8 weeks on the serum levels of ACE/ACE2 ratio in Jordanian participants with vitamin D deficiency (VDD).

Methods: The physical and clinical characteristic of individuals in both intervention and control randomized controlled clinical trial were measured and analyzed. The comparisons between the two groups and the changes in each group before and after taking omega-3 doses were studied through independent t test and paired t test, respectively. Possible factors that have a role in the changes were determined by multivariate stepwise regression. Follow-up period lasted 10 weeks.

Results: The sample consisted of 82 participants with VDD and a mean age of 37.85 ± 9.85 years. Omega-3 Supplements resulted in a significant decrease in serum ACE levels, ACE/ACE2 ratio and serum 25-hydroxy vitamin D (25OHD). While the change in serum ACE2 levels and serum triglycerides levels were insignificant. Also, a significant increase in serum LDL levels were observed.

Conclusion: It is possible that taking high doses of omega-3 fatty acid supplementations have positive effects on the heart and circulatory system and could protect from COVID-19 or decrease disease severity, in connection with a decrease in the ACE/ACE 2 ratio. On the other hand, omega-3 supplement may have negative effect on cardiovascular system due to the significant increase in serum LDL levels.

Keywords: 25- hydroxy vitamin D (25OHD); ACE; ACE/ACE2 ratio; ACE2; non-HDL; omega-3; vitamin D.

PubMed Disclaimer

Figures

Figure 1
Figure 1
CONSORT flow diagram for the study, indicating the number of subjects screened, recruited, and randomly assigned to the different intervention groups

Similar articles

References

    1. 1. Mahmudpour M, Roozbeh J, Keshavarz M, et al. COVID-19 cytokine storm:The anger of inflammation. Cytokine. 2020;133(1):155151. https://doi.org/10.1016/j.cyto.2020.155151 - PMC - PubMed
    2. Mahmudpour M, Roozbeh J, Keshavarz M, et al. COVID-19 cytokine storm:The anger of inflammation. Cytokine. 2020;133(1):155151. doi: 10.1016/j.cyto.2020.155151. - DOI - PMC - PubMed
    1. 2. Chaudhary M. COVID-19 susceptibility:potential of ACE2 polymorphisms. Egyptian Journal of Medical Human Genetics. 2020;21(1):1-8. https://doi.org/10.1186/s43042-020-00099-9 - PMC - PubMed
    2. Chaudhary M. COVID-19 susceptibility:potential of ACE2 polymorphisms. Egyptian Journal of Medical Human Genetics. 2020;21(1):1–8. doi: 10.1186/s43042-020-00099-9. - DOI - PMC - PubMed
    1. 3. Hess DC, Eldahshan W, Rutkowski E. COVID-19-Related Stroke. Translational Stroke Research. 2020;11(3):322-325. https://doi.org/10.1007/s12975-020-00818-9 - PMC - PubMed
    2. Hess DC, Eldahshan W, Rutkowski E. COVID-19-Related Stroke. Translational Stroke Research. 2020;11(3):322–325. doi: 10.1007/s12975-020-00818-9. - DOI - PMC - PubMed
    1. 4. Rico-Mesa JS, White A, Anderson AS. Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB. Current Cardiology Reports. 2020;22(5):31. https://doi.org/10.1007/s11886-020-01291-4 - PMC - PubMed
    2. Rico-Mesa JS, White A, Anderson AS. Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB. Current Cardiology Reports. 2020;22(5):31. doi: 10.1007/s11886-020-01291-4. - DOI - PMC - PubMed
    1. 5. Bosso M, Thanaraj TA, Abu-Farha M, et al. The Two Faces of ACE2:The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19. Molecular therapy. Methods &Clinical Development. 2020;18(1):321-327. https://doi.org/10.1016/j.omtm.2020.06.017 - PMC - PubMed
    2. Bosso M, Thanaraj TA, Abu-Farha M, et al. The Two Faces of ACE2:The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19. Molecular therapy. Methods &Clinical Development. 2020;18(1):321–327. doi: 10.1016/j.omtm.2020.06.017. - DOI - PMC - PubMed

LinkOut - more resources